Abstract

In the Netherlands around 50% of primary care COPD patients use inhaled corticosteroids (ICS), 30% of these probably have no appropriate indication Aim is 10% reduction in ICS (+-LABA) prescriptions for COPD patients A controlled pre/post intervention study with an incomplete control group (media-exposure). The intervention consisted of 1. Education within the regular “Pharmacotherapy meeting” between GP’s and pharmacists, 2. Providing GP’s with a flow chart to decide if the patient could safely stop their ICS, 3. Providing GP’s with a list of patients that might be suitable for de-implementation (patients>55 years who used ICS and had not received courses of predniso(lo)ne in the last year). Medication prescription data was gathered (all patients >55 years who received >2 prescriptions for copd/astma in the preceding 12 months). ICS (+/-LABA), LABA/LAMA, predniso(lo)ne, antibiotics and topical antimycotics were obtained before and after intervention. Intervention group data were compared to the rest of the country There was a significant decrease (11.4%) in ICS – ICS/LABA prescriptions in the whole group, however without significant differences between intervention and control group. See table 1 The 11.4% decrease in ICS prescriptions seems to be a national trend. Active de-implementation can play a role in promoting this. Decrease in ICS in COPD patients use does not seem to be accompanied by an increase in exacerbations

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call